What is AEON's current stock price?

AEON (AEON Biopharma, Inc.) is currently trading at $0.20 with a market cap of $8.7M.

What sector is AEON Biopharma, Inc. in?

AEON Biopharma, Inc. (AEON) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

AEON AEON Biopharma, Inc.

AMEXHealthcare

$0.1974+2.76%ClosedMarket Cap: $8.7M

As of 2026-08-24 16:00

Why AEON matters now

AEON Biopharma, Inc. (AEON) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.20 with +2.76% on the session and $8.7M in market capitalization.

The latest indexable market news headline is "AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer" from GlobeNewsWire.

Latest News

AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory OfficerGlobeNewsWire · 2026-08-24

AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX®GlobeNewsWire · 2026-08-19

AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate UpdateGlobeNewsWire · 2026-08-12

AEON Biopharma Regains Compliance with NYSE American Continued Listing StandardsGlobeNewsWire · 2026-08-03

Bitget Launchpool adds AEON (AEON) with 1.1M in Token RewardsGlobeNewsWire · 2026-07-27

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

AMEX

Beta

0.64

AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.